Concepedia

Jingyi Li

JL

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2023

Affiliations

Tianjin First Center Hospital(Current)

Jingyi Li is an author at Tianjin First Center Hospital specializing in immunotherapy, acute lymphoblastic leukemia therapy, and blinatumomab therapy.

ORCID

Publications per year

2023–2023

1

Publications

1

Blinatumomab as salvage therapy in patients with relapsed/refractory B-ALL who have failed/progressed after anti-CD19-CAR T therapy

Qi Yao, Hong Liu, Xin Li et al. · Annals of Medicine · 2023 · 15 citations · Full text

, , +15

1–1 of 1